Citi upgrades Medcath (Nasdaq: MDTH) from Sell to Hold.

Citi analyst says, "MDTH reported disappointing F4Q08 results and the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE